Total submissions: 1
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Ambry Genetics | RCV004150424 | SCV003635410 | uncertain significance | not specified | 2022-07-20 | criteria provided, single submitter | clinical testing | The c.38C>A (p.A13D) alteration is located in exon 1 (coding exon 1) of the NPC1L1 gene. This alteration results from a C to A substitution at nucleotide position 38, causing the alanine (A) at amino acid position 13 to be replaced by an aspartic acid (D). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. |